Health 10x Accelerator
Supporting Australia’s brightest health and medtech founders.
Designed and delivered in partnership with The George Institute for Global Health since 2019, the Health 10x accelerator supports startups developing affordable and scalable solutions to some of the most pressing unmet medical needs, globally.
Since 2019, health 10x have supported over 160 startups and invested in 33 startups built by the best and brightest health medical innovators across Australia.
In 2023, Virtus Health joined our mission to further support fertility and women’s health startups. As a global leader in reproductive assistive services, Virtus Health provide investment and commercialisation support to accelerate growth of Health 10x growing portfolio of women’s health startups.
This year, we’re proud to partner with UNSW Tyree Institute of Health Engineering (iHealthE) to further drive innovation. Startups will gain access to state-of-the-art facilities, collaboration spaces, and commercialisation specialists, enhancing their ability to create impactful solutions that transform global health outcomes.
Applications for 2024 are closed. Submit your EOIs for 2025
Previous info session: watch a recording here.
The Program
Health 10x Accelerator, a 10-week intensive program is tailored to equip health and medtech founders with business expertise and resources needed to understand the health technology ecosystem, build their company and drive impact through commercialisation.
We help the best and brightest innovators navigate the complex health and medtech commercialisation path from regulatory classifications, investment strategy to expanding operations, globally.
Program Benefits
Health 10x startups accepted into the Accelerator program receive:
10-week intensive program including weekly masterclasses, 1:1 with coaches and expert mentors, and your own Entrepreneur-in-Residence
$20k SAFE investment ($10K UNSW, $10K The George Institute for Global Health), with opportunity to follow on
$200k investment through our 2025 new capital partner
Fundraising strategy support, as wel as connections to domestic and international investors
Pitch to investors at our Investor Bootcamp and our invite-only Demo Day
Founders Perks up to value of $1M (AWS, Air table, startup services like accounting, insurance and legal)
Support package
Access to co-working space within Tyree IHealthE, including state-of-the-art facilities at Prince of Wales Hospital, access to clinical prototyping support
1:1 prototyping support and technical engineering support at the UNSW Makerspace (team have decades of hardware-realisation experience)
Regulatory workshop & preliminary assessment delivered by our regulatory partner (Platypus Medtech Consulting)
As part of a Global Mentoring Program, Health 10x startups gain access to direct industry mentorship by global leading pharmaceutical company AstraZeneca.
Business development and market research expertise from MBA intern/advisor support program
Expert coaches, R&D talent and infrastructure from UNSW and The George Institute for Global Health
Post Program Support
Co-Working Space & Mentorship
Health 10x alumni have opportunity to access six months of dedicated co-working space at UNSW Founders, alongside our Founders-in-Residence, or within Tyree IHealthE . This environment fosters collaboration, networking, and continued mentorship, ensuring startups receive the guidance needed to refine and scale their innovations.
Going Global
Through UNSW's Global Landing Pad, startups can tap into international networks, investor connections, and regulatory guidance to expand into key global markets. With entry points across Asia-Pacific, North America, Europe, and the Middle East, our program supports founders in navigating global commercialization challenges and forming strategic partnerships.
Additional Growth Support
Startups also benefit from non-dilutive grant funding opportunities, PR exposure, and PhD internships, further enhancing their development and industry engagement. Health 10x remains committed to supporting our startups beyond the accelerator, ensuring they have the resources to thrive in the health and medtech landscape.
Health 10x Helping Founders Take Their Idea to the Clinic
Sam van Bohemen (CEO and Co-Founder of nuroflux) joined Health 10x in 2021 mid-way into his PhD studies.
With a strong technical background as a biomedical engineer, Sam recognised the need for support to build his company and business, refine his medical device prototyping and connect with the right healthcare and research professionals.
Throughout Health 10x, Sam developed his commercialisation skills and took his device from a simple design to a clinic-ready device, from bench to bedside. The device is now in clinical trials with our key program delivery partner The George Institute for Global Health. Channel 9 New report below.
Meet The Founders Leading Women’s Health & Fertility Advancements
Catherine Slogrove from Amelia Bio
-
Catherine’s journey is deeply personal—after facing her own health challenges, she realised how the importance of vaginal health is overlooked. Frustrated by the lack of effective, accessible solutions, she became determined to create a product that empowers women to take control of their health.
Amelia Bio is her answer to a problem she once faced herself, driven by a mission to change the way we support and talk about women’s reproductive wellness.
Dr Steven Vasilescu from NeoGenix
-
As a biomedical engineer with a PhD in fluid systems, Steven discovered how current fertility practices often fall short. His passion stems from the realisation that male infertility is under-diagnosed yet deeply impactful in family planning. Combining his technical expertise with a personal drive to improve reproductive medicine, he is committed to reshaping fertility care with hardware and AI-driven technologies.
Ellen Gonda from GonGlobal
-
Ellen’s passion for innovation in reproductive health is rooted in her own IVF journey. Confronting the physical and emotional toll of fertility treatments firsthand, she saw an urgent need for better, less invasive solutions.
With GonGlobal, she is pioneering a new approach to IVF drug delivery—one that minimises discomfort and maximises accessibility. Her mission is clear: to revolutionise fertility care and ensure women have access to groundbreaking advancements that make the process easier and more effective.
Mark Grosser from 23Strands
-
Mark's work is deeply personal—his interest in genomics was sparked by his own family’s experience with health challenges that could have benefited from genetic insights. Frustrated by the one-size-fits-all approach in fertility care, he co-founded 23Strands to give patients data-backed, individualised solutions. His mission is to empower families with knowledge, ensuring that fertility treatments are as precise and effective as possible.
Health 10x Strategic Partners
Since, 2019, the Health 10x program has been designed and delivered in partnership With The George Institute for Global Health. thanks to our partners, startups gain access to clinical research expertise, vast medical research networks across the globe and a deep pool of leading researchers. Since then, we’ve expanded our partners to include leading organisations across medical research, commercialisation, and regulatory pathways, strengthening the support available to founders tackling global health challenges.
The George Institute for Global Health is a world-renowned medical research institute focused on improving health outcomes for underserved populations. As a founding partner of Health 10x, the Institute provides startups with access to clinical research expertise, real-world healthcare insights, and a global network of medical professionals and policy makers.
Virtus Health is a global leader and provider of assistive reproductive services and will support reproductive health startups by providing additional commercialisation support to fast-track their growth with access to strategic networks, expertise, and funding.
Platypus MedTech Consulting is a leading regulatory consultancy specialising in navigating the complex pathways for medtech and healthtech startups. Their expertise in regulatory strategy, compliance, and market access empowers startups to accelerate development and reach global markets with confidence.
Tyree Foundation Institute of Health Engineering is an interdisciplinary research institute at UNSW Sydney dedicated to advancing health technology innovation. Through its expertise in engineering, digital health, and biomedical sciences, Tyree IHealthE provides startups with access to cutting-edge research, technical capabilities, and commercialisation pathways to drive impactful health solutions.
Health 10x is further supported by leaders across healthcare, innovation and industry partners:
Genesys Electronics Design - A leading Australian electronics design firm specialising in the development of medical devices and embedded systems. By providing startups with access to world-class engineering expertise in hardware, firmware, and product design, Genesys supports the rapid prototyping and development of innovative medtech solutions, helping founders navigate the complexities of device commercialisation.
Randwick Health Innovation Precinct is a collaborative entity bringing together world-class education, research, and healthcare organisations to drive medical breakthroughs through translational research and industry collaboration. By fostering partnerships between startups, clinicians, and researchers, the precinct accelerates the development and adoption of innovative health technologies.
Liverpool Innovation Precinct is reimagining how health, education, and research are integrated to drive innovation and impact. By bringing together leading institutions, the precinct fosters collaboration between startups, clinicians, and researchers, enabling the co-creation of novel healthcare solutions.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines. Through its commitment to advancing innovation in healthcare, AstraZeneca supports startups by providing access to its industry expertise, research capabilities, and global networks to accelerate commercialisation and impact.
Meet a few of our Startups
Dr Peter Ayre, CardioBionic
-
CardioBionic (2019 alumni) is a pioneering medtech company dedicated to transforming heart failure treatment.
Their vision is to create a single, advanced control system platform for multiple cardiac support devices. This includes their VAS, an integrated digital control system managing ventricular assist devices (VADs) and cardiac catheters.
Their VADs, implantable pumps, offer vital support to compromised heart function, while the Cath, designed for acute heart failure, seamlessly integrates with the VAS for comprehensive care. CardioBionic's innovative approach promises improved outcomes and renewed hope for heart failure patients worldwide.
Dr Louise Metcalfe, Gheorg
-
Gheorg, (2023 alumni) is a healthtech company enhancing children's emotional intelligence and mental well-being through their innovative robot companion.
With a vision to empower children to cultivate resilience and effectively manage stress, Gheorg utilises cutting-edge technology to provide personalised support and guidance.
Their friendly robot, designed to engage and connect with children, serves as a valuable tool in fostering emotional growth and equipping young individuals with essential skills for navigating life's challenges.
Diana & Anastasia, Preview Health
Greg Miner, Evidentli
-
Evidentli (2019 alumni) s a dynamic medtech company revolutionising healthcare data management with their innovative platform.
Their cutting-edge technology swiftly standardises complex healthcare data and text with over 99% reliability in a matter of days, not months, and weeks, not years. By simplifying and unifying disparate clinical data, CardioBionic empowers healthcare communities worldwide to advance patient care and outcomes.
With Evidentli, healthcare professionals can entrust their data management needs, allowing them to focus on delivering exceptional care and driving meaningful progress in healthcare.
-
Preview Health (2024 alumni) is a pioneering medtech company dedicated to transforming the diagnosis of Parkinson's disease through advanced artificial intelligence (AI).
Their mission is to enable earlier and more accurate detection of Parkinson's, facilitating timely and personalised interventions to improve patient outcomes.
By leveraging AI-powered technology, Preview Health aims to revolutionise the diagnostic industry, starting with Parkinson's disease. Their innovative approach addresses the challenges of delayed and costly diagnoses by offering a streamlined process that enhances clinical confidence and reduces misdiagnosis.
Through their commitment to innovation and patient-centred care, Preview Health is poised to make a significant impact on the early detection and management of Parkinson's disease.
Read all about us in the news
